SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001011438-06-000417
Filing Date
2006-05-30
Accepted
2006-05-30 16:44:39
Documents
1
Group Members
GEORGE SOROS

Document Format Files

Seq Description Document Type Size
1 sc13d_npspharmaceuticals.txt SC 13D 38847
  Complete submission text file 0001011438-06-000417.txt   40692
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-44877 | Film No.: 06874465
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 (212) 872-1054
SOROS FUND MANAGEMENT LLC (Filed by) CIK: 0001029160 (see all company filings)

IRS No.: 133914976 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D